Literature DB >> 26221479

Gardenia jasminoides extracts and gallic acid inhibit lipopolysaccharide-induced inflammation by suppression of JNK2/1 signaling pathways in BV-2 cells.

Wen-Hung Lin1, Heng-Hung Kuo2, Li-Hsing Ho1, Ming-Lang Tseng3, An-Ci Siao4, Chang-Tsen Hung5, Kee-Ching Jeng6, Chien-Wei Hou4.   

Abstract

OBJECTIVES: Gardenia jasminoides Ellis (GJ, Cape Jasmine Fruit, Zhi Zi) has been traditionally used for the treatment of infectious hepatitis, aphthous ulcer, and trauma; however, the direct evidence is lacking.
MATERIALS AND METHODS: We investigated the effect of the GJ extract (GJ) and gallic acid (GA) on lipopolysaccharide (LPS) induced inflammation of BV-2 microglial cells and acute liver injury in Sprague-Dawley (SD) rats.
RESULTS: Our results showed that the GJ extract and GA reduced LPS-induced nitric oxide (NO), interleukin (IL)-1, IL-6, reactive oxygen species (ROS), and prostaglandin (PGE2) production in BV-2 cells. The GJ extract and GA significantly decreased serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in LPS-treated rats. Furthermore, the water extract, but not the ethanol extract, of the GJ dose-dependently inhibited LPS-induced JNK2/1 and slightly p38 mitogen-activated protein kinases (MAPK), and cyclooxygenase-2 (COX-2) expression in BV-2 cells.
CONCLUSION: Taken together, these results indicate that the protective mechanism of the GJ extract involves an antioxidant effect and inhibition of JNK2/1 MAP kinase and COX-2 expressions in LPS-induced inflammation of BV-2 cells.

Entities:  

Keywords:  BV-2[AGA1] cell; Gardenia jasminoides; MAPKs; NO; ROS

Year:  2015        PMID: 26221479      PMCID: PMC4509950     

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


Introduction

Gardenia jasminoides (GJ) is evergreen shrub of Rubiaceae, which is widely used in the treatment of infectious hepatitis, aphthous ulcer, and trauma in Asia. The pharmacological properties of this plant evaluated so far include anti-tumor and anti-inflammatory properties and reducing the risks of gastritis (1-3). The extract of Gardenia jasminoides Ellis, used to treat inflammation, was identified as geniposide. In vivo geniposide was found to plays an anti-inflammatory role via regulating TLR4 and downstream signaling pathways in LPS-induced mastitis in mice (2). It was also observed that geniposide attenuated histopathologic changes of mesenteric lymph node in adjuvant arthritis rats. Collectively, its anti-inflammatory and immune- regulatory effects might be mediated through down-regulating the expression of p-JNK (4). Hepatitis is commonly caused by pathogenic infection (including hepatitis viruses and Gram-negative bacteria), and alcohol- or drug-induced liver toxicity. Its pathology is initiated by a cascade of inflammatory events from viral-, alcohol-, or endotoxin-stimulated inflammatory cells and hepatic Kupffer cells to produce various pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, IL-12, and interferon (IFN)-γ (5-7). Lipopolysaccharides (LPS) can induce the Kupffer cells to produce reactive oxygen species (ROS) (8). Inflammatory response to stimuli or injury is often exacerbated by the resultant swelling or edema of tissue, pain (due to increased pressure in tissues or by inflammatory mediators), or even cell damage (9, 10). Therefore, chronic hepatitis leads to cirrhosis and eventually hepatocellular carcinoma. LPS-stimulated microglia, macrophages, and Kupffer cells activate phosphorylation and kinase activities of ERK1/2, c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK) and subsequently, cytokine production (11, 12). Evidence indicates that inducible COX may have both pro- and anti-inflammatory properties through the generation of different types of prostaglandins (13). Prostaglandin E2 (PGE2) strongly synergizes with the inflammatory cytokine. Thus, the employment of anti-inflammatory agents may be helpful in the treatment of various inflammatory conditions including hepatitis. It has been reported that Gposidic acid (iridoid glucoside) and genipin (protein) isolated from the GJ extract suppress serum tumor necrosis factor-alpha (TNF-α) and activation of hepatic lipid peroxidation, which was induced by GalN/LPS-induced liver toxicity (14, 15). Gallic acid (GA) is an organic acid found in foods such as blueberries, flaxseeds, tea leaves, and watercress. GA possesses significant anti-inflammatory properties and prevents the expression of inflammatory chemicals including cytokines and histamines (16). However, the mechanism of hepatoprotective effects of GJ extract and GA on LPS-induced liver toxicity has not been reported. Therefore, the aim of present study was to investigate the mechanism of anti-inflammatory effects of the water extract of GJ and GA using in vitro and in vivo models.

Materials and Methods

Reagents

LPS from Escherichia coli serotype 0111:B4 was obtained from Sigma (St. Louis, MO, USA). 2’,7’-Dichlorodihydrofluorescein diacetate (H2DCF-DA) was obtained from Molecular Probe (Eugene, Oregon, USA).

Activating agent

The GJ powder (100 mg) was added to 1 ml of RO water (reverse osmosis), mixed well by vortex for 5 min, and centrifuged at 2000 × g for 10 min. Finally, the GJ extract supernatant was filtered by sterile membrane.

Gallic acid content

GA content was determined by a procedure using 3% Na2CO3 solution and 5% Folin–Ciocalteu’s reagent. The Gardenia jasminoides infusion mixture was reacted for 30 min at room temperature before the absorbance at 760 nm was read. A standard curve was obtained from the gallic acid standard (Sigma-Aldrich Chemie GmbH, Munich, Germany) liquor in five different chroma using the method described by Zhu (17).

Animals

Male Sprague-Dawley rats (300-400 g) obtained from National Laboratory Animal Center (Taipei, Taiwan) and maintained in the Animal Center of Chinese Medical University (Taichung, Taiwan). The animal studies were performed following the guidelines from the Guidebook for the Care and Use of Laboratory Animals (2002) published by the Chinese Society of Animal Science in Taiwan. The rats were divided into six groups and fasted for 12 hr before intraperitoneal (IP) drug administration. One control group was given saline (blank), and the experimental group (L) was given 50 μg/kg of LPS. The GJ extract and GA groups were given 10 or 30 mg/kg of the Gardenia jasminoides extract and 1 or 10 mg/kg of gallic acid by gastric gavage after injection of LPS. Liver tissues were fixed with 10% formaldehyde solution overnight and stained with hematoxylin and eosin (H&E). Hepatic function was assessed by measuring serum alanine aminotranferease (ALT) and aspartate aminotransferase (AST) with an automatic blood analyzer (Hitachi High-Technologies, Tokyo, Japan).

Cell culture

Murine BV-2 cell line obtained from Taichung Veterans General Hospital, Taiwan, was maintained in DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a humidified incubator under 5% CO2. Confluent cultures were passed by trypsinization. For experiments, cells were washed twice with warm DMEM (without phenol red), and then treated in a serum-free medium. In all experiments, cells were treated with the GJ extract and GA for the indicated times after the addition of 2 μg/ml LPS as activating agent. The GJ extract and GA were dissolved in phosphate-buffered saline (PBS) and filtered through a 0.2 μM filter.

Nitric oxide assay

Nitrite, measured by Griess reaction, was taken as a measure of NO production. Briefly, 100 μl of culture supernatant (12–24 hr) was reacted with an equal volume of Griess reagent (1 part 0.1% naphthylethylene-diamine, 1 part 1% sulfanilamide in 5% H3PO4) in 96-well tissue culture plates for 10 min at room temperature in the dark. The absorbance at 540 nm was determined using a microplate reader (spectraMAX 340, Molecular Devices, Sunnyvale, CA, USA).

Cytokine assay

Cytokines (IL-1β, IL-6) and PGE2 were measured by ELISA kits (R&D, Minnespolis, MN, USA). The absorbance at 450 nm was determined using a microplate reader (spectraMAX 340). The TNF-α, IL-1β and IL-6 levels in the tissue supernatant were determined by ELISA kits (R&D). Protein concentration (pg/μg) in liver tissue was determined using a dye-based protein assay (Bio-Rad Laboratories, Hercules, CA, USA).

Reactive oxygen species generation

Intracellular accumulation of ROS was determined with H2DCF-DA. This nonfluorescent compound accumulates within cells upon deacetylation. H2DCF then reacts with ROS to form fluorescent dichlorofluorescein (DCF). BV-2 cells were plated in 96-well plates and grown for 24 hr before addition of DMEM plus 10 μM H2DCF, incubation for 60 min at 37 °C, and treatment with 1 mM H2O2 60 min. Cells were then washed twice with room temperature Hank’s balanced salt solution (HBSS without phenol red). Cellular fluorescence was monitored on a Fluoroskan Ascent fluorometer (Labsystems Oy, Helsinki, Finland) using an excitation wavelength of 485 nm and emission wavelength of 538 nm.

Serum AST/ALT

Serum levels of liver enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) reflect liver function and hepatocyte integrity. Concentrated blood samples were taken from tail veins by venipuncture during the experiment to measure the serum concentrations of AST and ALT in rats of each group. AST and ALT were detected by the automatic blood analyzer (Hitachi High-Technologies, Tokyo, Japan).

Preparation of cell extracts

The test medium was removed from culture dishes and cells were washed twice with ice-cold PBS, scraped off with a rubber policeman, and centrifuged at 200 ×g for 10 min at 4° C. The cell pellets were resuspended in an appropriate volume (approx. 4×107 cells/ml) of lysis buffer (20 Mm Tris–HCl, pH 7.5, 137 mM NaCl, 1 mM phenylmethylsulfonylfluoride (PMSF), 10 μg/ml aprotinin, 10 μg/ml leupeptin, and 5 lg/ml pepstain A), and sonicated. Protein concentration of samples was determined by Bradford assay (Bio-Rad, Hemel, Hempstead, UK), and samples equilibrated to 2 mg/ml with lysis buffer.

Western blotting

BV-2 cells were homogenized in ice-cold lysis buffer (1:10, wt/vol) containing 20 mmol/L 4-(2-hydroxyethyl)-1- piperazineethane sulfonic acid (pH 7.2), 1% Triton X-100, 10% glycerol, 1 mM PMSF, 10 μg/mL leupeptin, and 10 μg/ml aprotinin. This solution was centrifuged at 10,000 × g for 20 min at 4 °C. 50 μg of protein was run on an 8% or 10% sodium dodecyl sulfate-polyacrylamide gel and transferred onto nitrocellulose membranes (NEN Life Science, Boston, MA, USA) at 1.2 A for 3 hr. The membranes were blocked in 5% milk in Tris-buffered saline with Tween-20. The membrane was then incubated with polyclonal rabbit iNOS antibody (BD Biosciences, San Diego, CA, USA), and diluted 1:1000 in blocking buffer. Membranes were incubated with secondary anti-rabbit IgG conjugated to alkaline phosphatase (1:3000; Jackson ImmunoResearch, Philadelphia, PA, USA) and detected with alkaline phosphatase substrate solution (5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium) (Kirkegaard & Perry, Baltimore, MD, USA).

Statistical analysis

All data are expressed as mean±SD. For single variable comparisons, Student’s t-test was used. For multiple variable comparisons, data were analyzed by one-way ANOVA using Dunnett’s test. P-values of less than 0.05 or 0.01 were considered significant.

Results

GA contents of Gardenia jasminoides seeds

GA contents obtained from fresh and dry G. jasminoides seeds were 1.62±0.21 mg/g and 7.01±0.54 mg/g, respectively by reported assay method (17).

Effect of Gardenia jasminoides extract and gallic acid on nitrite production in LPS-stimulated BV-2 cells

We first tested whether the GJ extract could inhibit nitrogen free radicals. Murine BV-2 cell line obtained from Taichung Veterans General Hospital, Taiwan, was used as an inflammation model. BV-2 cells were stimulated with LPS (Escherichia coli serotype 0111:B4) and then treated with various concentrations of the GJ extract and GA for 24 hr. Nitrite content was measured using the Griess reaction. The results showed that nitrite production was inhibited dose-dependently by the GJ extract (Figure 1). Therefore, the GJ extract was used in further experiments.
Figure 1

Effect of the Gardenia jasminoides (GJ) extract on nitric oxide inhibition. BV-2 cells were stimulated with 2 μg/ml LPS and then treated with various concentrations of GJ extract or 1 μM gallic acid (GA) (positive control) for 24 hr. Nitrite production was measured by Griess reagent

Effect of the Gardenia jasminoides (GJ) extract on nitric oxide inhibition. BV-2 cells were stimulated with 2 μg/ml LPS and then treated with various concentrations of GJ extract or 1 μM gallic acid (GA) (positive control) for 24 hr. Nitrite production was measured by Griess reagent

Effect of GJ extract and GA on inflammatory cytokines

BV-2 cells were treated with 2 μg/ml LPS in combination with various concentrations (GA or GJ. GA contents that were obtained from fresh and dry G. jasminoides seeds were 1.62±0.21 mg/g and 7.01±0.54 mg/g, respectively) of GJ extract (1, 5, and 10 μg/ml) and 1 μM GA. Cultured supernatants were used to measure IL-1β and IL-6 by ELISA assay. The results showed that the GJ extract dose-dependently decreased IL-1β and IL-6 productions in BV-2 cells (Figure 2), and the effect of GJ on IL-6 production was more prominent than IL-1β.
Figure 2

Effect of the Gardenia jasminoides (GJ) extract on cytokine production. BV-2 cells were treated with 2 μg/ml LPS in the presence of 1, 5, and 10 μg/ml of GJ extract or 1 μM GA. GJ dose-dependently decreased IL-1β and IL-6 productions significantly (P<0:05)

Effect of the Gardenia jasminoides (GJ) extract on cytokine production. BV-2 cells were treated with 2 μg/ml LPS in the presence of 1, 5, and 10 μg/ml of GJ extract or 1 μM GA. GJ dose-dependently decreased IL-1β and IL-6 productions significantly (P<0:05)

Effect of GJ extract and GA on LPS-induced PGE2 release

To investigate the effect of GJ extract and GA on inflammation, PGE2 release was measured in the LPS-induced BV-2 cell culture. The results showed that GJ decreased PGE2 release from BV-2 cells dose-dependently (P<0:05, Figure 3).
Figure 3

Effect of the Gardenia jasminoides (GJ) extract on prostaglandin E2 production PGE2 released from LPS-induced BV-2 cell culture supernatant, was measured by ELISA. PGE2 was dose-dependently inhibited by the GJ extract (P<0:05)

Effect of the Gardenia jasminoides (GJ) extract on prostaglandin E2 production PGE2 released from LPS-induced BV-2 cell culture supernatant, was measured by ELISA. PGE2 was dose-dependently inhibited by the GJ extract (P<0:05)

Effect of GJ extract and GA on ROS generation

To investigate the antioxidant activity of GJ extract and GA on ROS generation, BV-2 cells were treated with H2O2 (1 mM) alone or with the GJ extract and GA. The ROS generation was increased by H2O2, but the generation of ROS was dose-dependently scavenged by the GJ extract (Figure 4).
Figure 4

Effect of the Gardenia jasminoides (GJ) extract on reactive oxygen species (ROS) generation. BV-2 cells were treated with H2O2 (1 mM) alone or with the GJ extract and gallic acid (GA) for one hour. The ROS generation was increased by H2O2, but it was dose-dependently scavenged by the GJ extract

Effect of the Gardenia jasminoides (GJ) extract on reactive oxygen species (ROS) generation. BV-2 cells were treated with H2O2 (1 mM) alone or with the GJ extract and gallic acid (GA) for one hour. The ROS generation was increased by H2O2, but it was dose-dependently scavenged by the GJ extract

Effect of GJ extract and GA on hepatic enzyme activity of SD rats

Anti-inflammatory effect of the GJ extract and GA were further studied in an acute hepatic injury model of SD rats. Rats were pretreated with GA (1 or 10 mg/kg) or the GJ extract (10 or 30 mg/kg) for three days, and then injected with 50 μg/kg LPS to induce liver injury. Both GJ extract and GA supplementation decreased serum AST and ALT levels as compared to the LPS control (Figure 5).
Figure 5

The anti-inflammatory effect of the Gardenia jasminoides (Gj) extract in an acute hepatic injury model. SD rats were pretreated with gallic acid (GA) (1 mg/kg) or the GJ extract (10 or 30 mg/kg) for three days, and then injected with 50 μg/kg LPS to induce liver injury. Both the GJ extract and GA supplementation decreased serum AST and ALT levels as compared to the LPS control

The anti-inflammatory effect of the Gardenia jasminoides (Gj) extract in an acute hepatic injury model. SD rats were pretreated with gallic acid (GA) (1 mg/kg) or the GJ extract (10 or 30 mg/kg) for three days, and then injected with 50 μg/kg LPS to induce liver injury. Both the GJ extract and GA supplementation decreased serum AST and ALT levels as compared to the LPS control

Effect of GJ extract and GA on LPS-induced MAPKs and COX-2 expression

The effect of GJ extract and GA on cell signaling was investigated both in vitro and in vivo. The GJ extract dose-dependently inhibited LPS-induced JNK, and p38 MAPK, and partially inhibited COX-2 in BV-2 cells. Similarly, the GJ extract inhibited LPS-induced p38 MAPK, and partially inhibited COX-2 in the livers of SD rats (Figure 6).
Figure 6

The effect of the Gardenia jasminoides (GJ) extract and gallic acid (GA) on cell signaling was investigated in BV-2 cells. The GJ extract dose-dependently inhibited LPS-induced JNK2/1, partially p38 MAPK, and inhibited COX-2 in BV-2 cells. GA (1 μM) only inhibited LPS-induced JNK2/1 MAPK partially

The effect of the Gardenia jasminoides (GJ) extract and gallic acid (GA) on cell signaling was investigated in BV-2 cells. The GJ extract dose-dependently inhibited LPS-induced JNK2/1, partially p38 MAPK, and inhibited COX-2 in BV-2 cells. GA (1 μM) only inhibited LPS-induced JNK2/1 MAPK partially

Effect of GJ extract and GA on LPS-induced hepatic injury of rats

To analyze the effects of GJ extract and GA on LPS-induced hepatic injury of rats, we also examined the liver pathology. Lesions and leukocyte infiltration were prominently induced in LPS-treated rats; however, this pathology was greatly reduced in the GJ extract and GA-treated rats (Figure 7).
Figure 7

Protective effect of the Gardenia jasminoides (GJ) Extract and gallic acid (GA) on LPS-induced hepatic injury in SD rats. Liver slices from rats with no treatment (A, control) or treated with 50 μg/kg LPS IP (B), and supplemented with 10 mg/kg GA (C) and 30 mg/kg the GJ extract (D) showed the differences in liver pathology. Photographs show the liver slices from rats with 400 × magnification. Partial to extensive vacuolar degeneration of liver cells in LPS stimulated rats was significantly higher than the others, but, this pathology was reduced in the GJ extract and GA-treated rats

Protective effect of the Gardenia jasminoides (GJ) Extract and gallic acid (GA) on LPS-induced hepatic injury in SD rats. Liver slices from rats with no treatment (A, control) or treated with 50 μg/kg LPS IP (B), and supplemented with 10 mg/kg GA (C) and 30 mg/kg the GJ extract (D) showed the differences in liver pathology. Photographs show the liver slices from rats with 400 × magnification. Partial to extensive vacuolar degeneration of liver cells in LPS stimulated rats was significantly higher than the others, but, this pathology was reduced in the GJ extract and GA-treated rats

Discussion

Our results showed that the GJ extract and GA protected rats from LPS-induced injury. Hepatic lesions and leukocyte infiltration were prominently reduced by the GJ extract and GA treatment. In addition, the levels of AST and ALT were decreased by the GJ extract and GA significantly. This hepatoprotective effect was consistent with the effects of GJ extract on other reports such as concanavalin A, or carbon tetrachloride (CCl4), and hydrophilic bile acids[AGA8] activity (18-20). Partial to extensive vacuolar degeneration of liver cells were prominently induced in LPS-treated rats. However, this pathology was greatly reduced in the GJ extract and GA-treated rats (Figure 7). The results of this study showed that the PR extract and resveratrol protected rats from LPS-induced injury. Hepatic lesions and leukocyte infiltration were prominently reduced by the GJ extract and GA treatment. In addition, the levels of AST and ALT were decreased by the PR extract and resveratrol significantly. Thus, this hepatoprotective effect is consistent with the effects of resveratrol on mice or rats subjected to CC14, or LPS, D-GaIN, and dimethylnitrosamine [AGA9](21, 22). Therefore, our result confirmed that LPS-induced MAPKs such as ERK (Extracellular signal-regulated kinases and p38 may also contribute to acute liver injury. Nevertheless, other studies had demonstrated that JNK and p38 MAPKs activation following liver ischemia and reperfusion are associated with the induction of apoptosis and necrosis, while inhibitors of p38 and JNK can reduce the liver damage (6, 22). Our results clearly showed that the mechanism of hepatoprotective effect by the GJ extract was mainly due to the suppression of p38 MAPK and, to a lesser degree, of COX-2. During liver fibrosis formation, JNK and p38 might have opposite effects (23). It has been shown that chronic alcohol induces LPS-induced p38 and ERK1/2 activation, but decreases JNK in murine hepatic macrophages (24). Therefore, LPS-induced MAPKs such as ERK and p38 may also contribute to acute liver injury. The mechanism of the hepatitis virus in causing liver injury also involves the MAPKs pathway. Studies have shown that hepatitis B, C, and E viruses (HBV, HCV and HEV) modulate the MAPK signaling pathway (27). Studies have also shown that deregulated MAPKs are often found to contribute in the development of many cancers, including hepatocarcinoma (HCC). The early studies on the ERK pathway have led to the development of the multikinase inhibitor Sorafenib, the first effective systemic drug for the targeted treatment of human HCC. In addition, the functions and molecular mechanisms of JNK and p38 in HCC development have also been addressed using mouse models (28). Our findings on the suppression of JNK2/1 MAPK by the GJ extract and GA was consistent with these hepatoprotective mechanisms. Geniposide (Gen), the extract of the GJ has been recently identified as a bioactive iridoid glucoside that has anti-inflammatory effect; in addition, it enhances the intestinal absorption, and protects against hyperlipidemia (29-31). However, other active components of the water extract of the GJ have not been identified. The researchers of the study state that GA may be used to treat inflammatory allergic diseases. GA is one rich compound of the GJ (0.16% fresh seeds, 0.7% dry seeds). Nevertheless, our present data showed that water extract of GJ and GA reduced LPS-induced NO, IL-1β, IL-6, ROS, and PEG2 production in BV-2 cells.

Conclusion

The GJ extract and GA reduced JNK2/1, and p38 MAPKs phosphorylation, and slightly reduced COX-2 expression in BV-2 cells in a dose-dependent manner. Antioxidant effects could also be shown in the LPS-induced liver injury in SD rats, since the JNK2/1 MAPK phosphorylation and COX-2 expression were similarly reduced by GJ extract and GA treatment.
  31 in total

1.  Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.

Authors:  Kazuko Kojima; Tsutomu Shimada; Yasuhiro Nagareda; Michiru Watanabe; Junko Ishizaki; Yoshimichi Sai; Ken-ichi Miyamoto; Masaki Aburada
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

2.  Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins.

Authors:  B Poligone; A S Baldwin
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

3.  Hepatoprotective and hypolipidaemic effects of glycoprotein isolated from Gardenia jasminoides ellis in mice.

Authors:  Sei-Jung Lee; Phil-Sun Oh; Kye-Taek Lim
Journal:  Clin Exp Pharmacol Physiol       Date:  2006-10       Impact factor: 2.557

4.  Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.

Authors:  Seok-Joo Kim; Joon-Ki Kim; Dong-Ung Lee; Jong-Hwan Kwak; Sun-Mee Lee
Journal:  Eur J Pharmacol       Date:  2010-03-19       Impact factor: 4.432

5.  Hepatoprotective effect of shidagonglao on acute liver injury induced by carbon tetrachloride.

Authors:  Jung Chao; Meng-Shiou Lee; Sakae Amagaya; Jiunn-Wang Liao; Jin-Bin Wu; Li-Kang Ho; Wen-Huang Peng
Journal:  Am J Chin Med       Date:  2009       Impact factor: 4.667

Review 6.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

7.  Gardenia jasminoides Ellis ethanol extract and its constituents reduce the risks of gastritis and reverse gastric lesions in rats.

Authors:  Je-Hyuk Lee; Dong-Ung Lee; Choon-Sik Jeong
Journal:  Food Chem Toxicol       Date:  2009-06       Impact factor: 6.023

Review 8.  Cellular and molecular mechanisms of liver injury.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

9.  An investigation of the anti-inflammatory and analgesic effects of Orthosiphon stamineus leaf extract.

Authors:  Mun Fei Yam; Mohd Zaini Asmawi; Rusliza Basir
Journal:  J Med Food       Date:  2008-06       Impact factor: 2.786

10.  Kinetics of mitogen-activated protein kinase family in lipopolysaccharide-stimulated mouse Kupffer cells and their role in cytokine production.

Authors:  Jian-Xin Jiang; Yu Zhang; San-He Ji; Peifang Zhu; Zheng-Guo Wang
Journal:  Shock       Date:  2002-10       Impact factor: 3.454

View more
  18 in total

1.  Genoprotective effects of gallic acid against cisplatin induced genotoxicity in bone marrow cells of mice.

Authors:  S Shruthi; K Bhasker Shenoy
Journal:  Toxicol Res (Camb)       Date:  2018-06-15       Impact factor: 3.524

2.  Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production.

Authors:  Naohiro Oshima; Tomofumi Shimizu; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2018-04-18       Impact factor: 2.343

3.  Gallic acid, a phenolic compound isolated from Mimosa bimucronata (DC.) Kuntze leaves, induces diuresis and saluresis in rats.

Authors:  Fabile Schlickmann; Thaise Boeing; Luisa Nathália Bolda Mariano; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Luisa Mota da Silva; Sérgio Faloni de Andrade; Priscila de Souza; Valdir Cechinel-Filho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-16       Impact factor: 3.000

4.  Anti-inflammatory activities of Gardenia jasminoides extracts in retinal pigment epithelial cells and zebrafish embryos.

Authors:  Jianrong Chen; Gabriel Mbuta Tchivelekete; Xinzhi Zhou; Weizhuo Tang; Fang Liu; Minzhuo Liu; Chenxi Zhao; Xinhua Shu; Zhihong Zeng
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

5.  Anti-inflammatory effect of longan seed extract in carrageenan stimulated Sprague-Dawley rats.

Authors:  Ching-Hsiao Lee; Yuh-Shuen Chen; Chien-Wei Hou; Kee-Ching Jeng; Kuo-Shu Chen
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

6.  Herbal formula SC-E1 suppresses lipopolysaccharide-stimulated inflammatory responses through activation of Nrf2/HO-1 signaling pathway in RAW 264.7 macrophages.

Authors:  Ju-Yeon Park; Young-Won Kwon; Soo Chil Lee; Sun-Dong Park; Ju-Hee Lee
Journal:  BMC Complement Altern Med       Date:  2017-07-28       Impact factor: 3.659

7.  ANTI-INFLAMMATORY ACTIVITY OF EUCALYPTUS SPP. AND PISTASCIA LENTISCUS LEAF EXTRACTS.

Authors:  Khaled Qabaha; Sari Abu Ras; Jehad Abbadi; Fuad Al-Rimawi
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-08-12

8.  Pharmacological effects of a synthetic quinoline, a hybrid of tomoxiprole and naproxen, against acute pain and inflammation in mice: a behavioral and docking study.

Authors:  Hossein Hosseinzadeh; Fatemeh Mazaheri; Razieh Ghodsi
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

9.  Antiviral Activities of Several Oral Traditional Chinese Medicines against Influenza Viruses.

Authors:  Lin-Lin Ma; Miao Ge; Hui-Qiang Wang; Jin-Qiu Yin; Jian-Dong Jiang; Yu-Huan Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-08       Impact factor: 2.629

10.  A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification.

Authors:  Jingyuan Zhang; Xinkui Liu; Wei Zhou; Guoliang Cheng; Jiarui Wu; Siyu Guo; Shanshan Jia; Yingying Liu; Bingbing Li; Xiaomeng Zhang; Miaomiao Wang
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.